Genetic Mutation Analysis Market is anticipated to expand from 5.2 billion in 2024 to 11.3 billion b
The Genetic Mutation Analysis Market encompasses the industry dedicated to identifying and characterizing genetic alterations to understand disease mechanisms, inform diagnosis, and guide treatment strategies. It includes technologies such as next-generation sequencing, PCR, and microarrays, serving sectors like healthcare, pharmaceuticals, and research institutions, thereby driving advancements in personalized medicine and genomics.